Diclazuril
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C₁₇H₉Cl₃N₄O₂ 407.64
Benzeneacetonitrile, 2,6-dichloro-α-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-;
(p-Chlorophenyl)[2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3H)-yl)phenyl]acetonitrile CAS RN®: 101831-37-2; UNII: K110K1B1VE
1 DEFINITION
Diclazuril contains NLT 97.0% and NMT 101.0% of C₁₇H₉Cl₃N₄O₂, calculated on the dried basis.
2 IDENTIFICATION
Change to read:
Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K
3 ASSAY
3.1 Procedure
Buffer: Dissolve 6.3 g of ammonium formate in 800 mL of water, adjust with anhydrous formic acid to a pH of 4.0, and add 200 mL of water.
Solution A: Acetonitrile, water, and Buffer (3:15:2)
Solution B: Acetonitrile, water, and Buffer (85:5:10)
Mobile phase: See the gradient table below.
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 20 | 0 | 100 |
| 25 | 0 | 100 |
| 26 | 100 | 0 |
| 36 | 100 | 0 |
Standard solution: 0.5 mg/mL of USP Diclazuril RS in dimethylformamide
System suitability solution: 0.5 mg/mL of USP Diclazuril System Suitability Mixture RS in dimethylformamide
Sample solution: 0.5 mg/mL of Diclazuril in dimethylformamide
Chromatographic system
- (See Chromatography 〈621〉, System Suitability.)
- Mode: LC
- Detector: UV 230 nm
- Column: 4.6-mm × 10-cm; base-deactivated 3-µm packing L1
- Flow rate: 1 mL/min
- Column temperature: 35°
- Injection size: 5 µL
System suitability
- Samples: Standard solution and System suitability solution
- Suitability requirements
- Resolution: NLT 1.9 between diclazuril and diclazuril ketone peaks, System suitability solution
- Tailing factor: NMT 1.4, Standard solution
- Relative standard deviation: NMT 2.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of C₁₇H₉Cl₃N₄O₂ in the portion of Diclazuril taken:
Result = (rᵤ/rₛ) × (Cₛ/Cᵤ) × 100
rᵤ = peak response from the Sample solution
rₛ = peak response from the Standard solution
Cₛ = concentration of USP Diclazuril RS in the Standard solution (mg/mL)
Cᵤ = concentration of Diclazuril in the Sample solution (mg/mL)
Acceptance criteria: 97.0%–101.0% on the dried basis
4 IMPURITIES
4.1 Inorganic Impurities
4.1.1 Residue On Ignition 〈281〉: NMT 0.1%
4.2 Organic Impurities
4.2.1 Procedure 1: Residual Solvents 〈467〉
Acceptance criteria: NMT 4000 ppm of N,N-dimethylformamide
4.2.2 Procedure 2
Buffer, Solution A, Solution B, Mobile phase, Standard solution, System suitability solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay.
Analysis
Samples: Standard solution and Sample solution
Calculate the area percentage of each impurity, relative to diclazuril, in the portion of Diclazuril taken:
Result = (rᵤ/rₛ) × (Cₛ/Cᵤ) × (1/F) × 100
rᵤ = peak response of each impurity from the Sample solution
rₛ = peak response of diclazuril from the Standard solution
Cₛ = concentration of USP Diclazuril RS in the Standard solution (mg/mL)
Cᵤ = concentration of Diclazuril in the Sample solution (mg/mL)
F = relative response factor (see Impurity Table 1)
Acceptance criteria
[Note-Disregard any peak observed in the blank. The reporting level for impurities is 0.05%.]
Individual impurities: See Impurity Table 1.
Total impurities: NMT 1.5%
Impurity Table 1
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| 6-Carboxylic acidᵃ | 0.62 | 0.85 | 0.50 |
| 6-Carboxamideᵇ | 0.80 | 0.92 | 0.50 |
| Diclazuril | 1.00 | - | - |
| Ketoneᶜ | 1.03 | 0.52 | 0.10 |
| 4-Amino derivativeᵈ | 1.09 | 0.81 | 0.50 |
| Des-cyano derivativeᵉ | 1.16 | 1.1 | 0.50 |
| Trichlorodiphenyl acetonitrileᶠ | 1.24 | 0.71 | 0.50 |
| Any other individual impurity | - | 1.0 | 0.20 |
ᵃ (RS)-2-[3,5-Dichloro-4-[(4-chlorophenyl)cyanomethyl]phenyl]-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carboxylic acid.
ᵇ (RS)-2-[3,5-Dichloro-4-[(4-chlorophenyl)cyanomethyl]phenyl]-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carboxamide.
ᶜ 2-[3,5-Dichloro-4-(4-chlorobenzoyl)phenyl]-1,2,4-triazine-3,5(2H,4H)-dione.
ᵈ (RS)-2-(4-Amino-2,6-dichlorophenyl)-2-(4-chlorophenyl)acetonitrile.
ᵉ 2-[3,5-Dichloro-4-(4-chlorobenzyl)phenyl]-1,2,4-triazine-3,5(2H,4H)-dione.
ᶠ (RS)-2-(4-Chlorophenyl)-2-(2,6-dichlorophenyl)acetonitrile.
5 SPECIFIC TESTS
Loss On Drying, 〈731〉: Dry a sample at between 100° and 105° under a vacuum for 4 h: it loses NMT 0.5% of its weight.
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers, and store at room temperature.
Labeling: Label it to indicate that it is for veterinary use only.
USP Reference Standards 〈11〉
- USP Diclazuril RS
- USP Diclazuril System Suitability Mixture RS
Contains diclazuril and specified impurities.

